Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.
about
Hyperlipidemia, tissue factor, coagulation, and simvastatinIncreased 18F-FDG uptake is predictive of rupture in a novel rat abdominal aortic aneurysm rupture model.Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.Low-molecular-weight heparin modulates vein wall fibrotic response in a plasminogen activator inhibitor 1-dependent manner.The role of galectin-3 and galectin-3-binding protein in venous thrombosis.Critical review of mouse models of venous thrombosis.Swine Model of Thrombotic Caval Occlusion Created by Autologous Thrombus Injection with Assistance of Intra-caval Net Knitting.Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects.Anti-hyperlipidemic activity of Rhynchosia nulubilis seeds pickled with brown rice vinegar in mice fed a high-fat diet.Signaling pathways of apoE and its role of gene expression in glomerulus diseases.Signaling pathway factors expression in renal tissue of apoE-knockout mice.Integrating microRNA and messenger RNA expression profiles in a rat model of deep vein thrombosis.Inferior vena cava branch variations in C57BL/6 mice have an impact on thrombus size in an IVC ligation (stasis) model.Animal models of venous thrombosis.Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis.Mouse models of cancer-associated thrombosis.Pathophysiology of venous thrombosis.The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse.
P2860
Q27024964-1F8F83BA-5009-42DB-8201-64E65B983800Q27312594-778271B2-86D9-411E-BC79-1E05704C5DF0Q34021916-F16CBC81-9CD1-477C-B994-11005C211D0CQ34324817-5263D0A7-D325-44A5-BC08-D25CF68A7E3EQ34530252-81A4E6AB-DAC7-4FBF-8072-AF66004C99BBQ35171280-06FFA925-EE83-4A60-AF7E-AB72F6EFFD38Q35796005-FF23127B-4B0E-471C-9639-6C6299933C04Q36382925-6D6EA5B0-17CF-4FC0-877E-CD7BD97452E1Q36674896-0D5F8383-85A3-4A17-91A0-3B29B6654E65Q37397416-D193B17A-46F3-48A1-A435-95DCEC552249Q38079285-4301067D-7CC2-4519-BB60-11E7F38E1382Q38533698-98C5CF7F-2780-4F6F-B283-7FA9DB888BD2Q41352432-E16F9EA2-E496-43F9-B639-1CA5A88D0B66Q47405569-D66808B2-6B24-40C6-8E41-2944BEE3864CQ49178526-61E028A0-689F-453C-B7BA-30D4C98F9A8CQ49470799-121B7241-3DC6-4981-A486-6BCB10AD1539Q50148338-A91D5C4A-EB66-4215-9402-0210942CBFECQ53599197-5E8FCFAC-1131-4C79-9828-9E6DD9E5C1ECQ55070348-2CEB1EE6-156C-429D-972F-ED02336B07AE
P2860
Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Impaired fibrinolytic system i ...... augments deep vein thrombosis.
@ast
Impaired fibrinolytic system i ...... augments deep vein thrombosis.
@en
type
label
Impaired fibrinolytic system i ...... augments deep vein thrombosis.
@ast
Impaired fibrinolytic system i ...... augments deep vein thrombosis.
@en
prefLabel
Impaired fibrinolytic system i ...... augments deep vein thrombosis.
@ast
Impaired fibrinolytic system i ...... augments deep vein thrombosis.
@en
P2093
P2860
P1476
Impaired fibrinolytic system i ...... augments deep vein thrombosis.
@en
P2093
Angela E Hawley
Daniel A Lawrence
Daniel D Myers
Diana M Farris
Jose A Diaz
Nicole E Ballard-Lipka
Peter K Henke
Shirley K Wrobleski
Thomas W Wakefield
P2860
P304
P356
10.1016/J.JVS.2011.08.038
P577
2011-11-25T00:00:00Z